Pedro Paulo Xavier Elsas

Pedro Xavier Elsas possui graduação em Medicina pela Universidade Federal do Rio de Janeiro (1979), mestrado em Ciências Biológicas (Biofísica) pela Universidade Federal do Rio de Janeiro (1981) e doutorado em Ciências (Microbiologia) pela Universidade Federal do Rio de Janeiro (1990). Sua formação no Exterior foi feita como Research Fellow na Harvard Medical School, Boston, EUA (1981-1984, Patologia e Medicina), no Centre d'Immunologie INSERM-CNRS de Marseille-Luminy (Marseille-França) e na Roche Research Gent (Gent, Bélgica). Passou um ano sabático (2005) como Visiting Professor of Medicine, Harvard Medical School. Atualmente é Professor Titular da Universidade Federal do Rio de Janeiro. Recebeu bolsa de produtividade em pesquisa pelo CNPq durante as últimas duas décadas. Foi de 2011 a 2014 Cientista do Nosso Estado pela Fundação de Amparo à Pesquisa Carlos Chagas Filho, (FAPERJ). Tem experiência na área de Imunologia, com ênfase em Imunopatologia, atuando principalmente nos seguintes temas: hematopoiese, citocina, eosinofilos, citocinas e alergia. Atua como referee para muitos journals internacionais e é atualmente membro do corpo editorial do Biomedical Research International e do Current Cancer Therapy Reviews. É Review Editor do Frontiers in Medicine/Frontiers in Public Health e faz parte do Frontiers.org COVID-19 task force.

Pedro Xavier-Elsas holds a Medical Doctor degree (1979), a M. Sc. degree in Biological Sciences (Biophysics; 1981) and a doctorate in Science (Microbiology, 1990), all from the Federal University of Rio de Janeiro, Brazil. His professional training abroad was done initially as a Research Fellow at Harvard Medical School, Boston, USA (1981-1984, Pathology and Medicine). Subsequently he joined the Centre d'Immunologie INSERM-CNRS de Marseille-Luminy (France) and was a Visiting Science at Roche Research Gent (Belgium). He spent a sabbatical year as Visiting Professor of Medicine, Harvard Medical School. He is currently a Full Professor at the Dept. of Immunology, Instituto de Microbiologia Paulo de Góes (UFRJ). He has been the recipient of Research Productivity Awards from CNPq for the last two decades, and was awarded a Cientista do Nosso Estado grant from FAPERJ, 2011-2014. Has professional experience in the field of Immunology, with a focus on Immunopathology. His research activity is concerned with the following themes: hematopoiesis, cytokines, eosinophils, allergy. He acts as referee for many international journals and is currently a member of the editorial board of Biomedical Research International and of Current Cancer Therapy Reviews. He is a Review Editor for Frontiers in Medicine/Frontiers in Public Health and a member of the Frontiers.org COVID-19 task force.